MDWD
Mediwound LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$218.10M
P/E Ratio
—
EPS
$-2.10
Beta
0.15
52W High
$22.50
52W Low
$14.90
50-Day MA
$17.24
200-Day MA
$18.08
Dividend Yield
—
Profit Margin
-140.80%
Forward P/E
34.97
PEG Ratio
-0.07
About Mediwound Ltd
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
Fundamentals
| Revenue (TTM) | $16.96M |
| Gross Profit (TTM) | $3.25M |
| EBITDA | $-24.28M |
| Operating Margin | -417.80% |
| Return on Equity | -63.90% |
| Return on Assets | -19.80% |
| Revenue/Share (TTM) | $1.49 |
| Book Value | $3.40 |
| Price-to-Book | 4.94 |
| Price-to-Sales (TTM) | 12.86 |
| EV/Revenue | 10.06 |
| EV/EBITDA | -6.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -68.00% |
| Shares Outstanding | $12.85M |
| Float | $9.89M |
| % Insiders | 15.86% |
| % Institutions | 56.98% |
Analyst Ratings
Consensus ($31.33 target)
1
Strong Buy5
BuyData last updated: 4/8/2026